Search clinical trials for: Venetoclax and Decitabine
Total 272551 results
-
Gruppo Italiano Trapianto di Midollo OsseoCompletedAcute Myeloid LeukemiaItaly
-
The First Affiliated Hospital of Soochow UniversityRecruitingAcute Myeloid Leukemia, AdultChina
-
Gruppo Italiano Malattie EMatologiche dell'AdultoRecruiting
-
The First Affiliated Hospital of Soochow UniversityNot yet recruitingB-cell Acute Lymphoblastic LeukemiaChina
-
The First Affiliated Hospital with Nanjing Medical...Huai'an First People's Hospital; Yancheng First People's Hospital; The Affiliated...RecruitingAcute Myeloid LeukemiaChina
-
Cyclacel Pharmaceuticals, Inc.M.D. Anderson Cancer CenterUnknownAcute Myeloid Leukemia | Myelodysplastic SyndromesUnited States
-
Novartis PharmaceuticalsRecruitingMyelodysplastic Syndromes | Leukemia, Myelomonocytic, ChronicSpain, Italy, Czechia, Malaysia, Turkey, China, United States, Greece, Brazil
-
The Second Affiliated Hospital of Kunming Medical...Not yet recruitingAcute Myeloid Leukemia | Decitabine | Venetoclax | Elderly AML Patients | Unfit, New-diagnosis AMLChina
-
Beijing 302 HospitalNot yet recruitingRefractory Acute Myeloid Leukemia | Minimal Residual Disease | Relapsed Acute Myeloid Leukemia
-
Astex Pharmaceuticals, Inc.Active, not recruitingAcute Myeloid LeukemiaUnited States, Spain, Canada
-
Montefiore Medical CenterRecruitingAML | MDSUnited States
-
University of ChicagoAbbVieRecruitingAcute Myeloid LeukemiaUnited States
-
M.D. Anderson Cancer CenterRecruitingAcute Myeloid Leukemia | Recurrent Acute Myeloid Leukemia | Refractory Acute Myeloid LeukemiaUnited States
-
M.D. Anderson Cancer CenterActive, not recruitingRecurrent Acute Myeloid Leukemia | Refractory Acute Myeloid Leukemia | Recurrent Acute Biphenotypic Leukemia | Refractory Acute Biphenotypic LeukemiaUnited States
-
M.D. Anderson Cancer CenterGenentech, Inc.; Astex Pharmaceuticals, Inc.RecruitingChronic Myelomonocytic Leukemia | Myelodysplastic SyndromeUnited States
-
Bio-Path Holdings, Inc.RecruitingAcute Myeloid Leukemia (AML)United States
-
Ospedale Maggiore Di TriesteUnknownAcute Myeloid Leukemia, Adult | Hypomethylating Agents | VenetoclaxItaly
-
University Hospital TuebingenRecruiting
-
Benjamin TomlinsonNot yet recruitingAcute Myeloid Leukemia | Myeloid MalignancyUnited States
-
M.D. Anderson Cancer CenterAstex Pharmaceuticals, Inc.; Syndax PharmaceuticalsRecruiting
-
PureTechRecruiting
-
Shanghai General Hospital, Shanghai Jiao Tong University...RecruitingMyeloid Malignancy | Venetoclax | Hypomethylating AgentChina
-
PrECOG, LLC.Genentech, Inc.CompletedFollicular Lymphoma | Non-Hodgkin's Lymphoma Follicular | Non-Hodgkin's Lymphoma, Adult High GradeUnited States
-
Virginia Commonwealth UniversityAbbVieWithdrawnRelapsed Small Cell Lung Cancer | Refractory Small Cell Lung Carcinoma
-
M.D. Anderson Cancer CenterRecruitingAcute Myeloid Leukemia | Recurrent Acute Myeloid Leukemia | Refractory Acute Myeloid LeukemiaUnited States
-
University of Maryland, BaltimoreActive, not recruitingRelapsed or Refractory Acute Myeloid LeukemiaUnited States
-
M.D. Anderson Cancer CenterRigel Pharmaceuticals,Inc.Not yet recruitingMutant IDH1 Inhibitor OlutasidenibUnited States
-
Jacqueline Garcia, MDAbbVieRecruitingAcute Myeloid Leukemia | Myelodysplastic Syndromes | Myelofibrosis | Myeloid Malignancy | Myeloproliferative NeoplasmUnited States
-
Stichting Hemato-Oncologie voor Volwassenen NederlandNordic Lymphoma GroupActive, not recruiting
-
Yale UniversityCompleted
-
M.D. Anderson Cancer CenterRecruitingAcute Myeloid Leukemia | Myelodysplastic Syndrome | Recurrent Acute Myeloid Leukemia | Refractory Acute Myeloid LeukemiaUnited States
-
BioSight Ltd.Recruiting
-
National Cancer Institute (NCI)RecruitingChronic Myelomonocytic Leukemia | Myelodysplastic Syndrome | Myelodysplastic Syndrome With Excess Blasts | Myeloproliferative NeoplasmUnited States, Canada
-
University of FloridaNot yet recruiting
-
Sanjay MohanNational Comprehensive Cancer Network; Taiho Oncology, Inc.RecruitingRecurrent Acute Myeloid LeukemiaUnited States
-
Gruppo Italiano Malattie EMatologiche dell'AdultoRecruiting
-
Aptose Biosciences Inc.RecruitingRelapsed or Refractory Acute Myeloid LeukemiaUnited States, Germany, Spain, Korea, Republic of, Australia, New Zealand
-
Anhui Provincial HospitalRecruitingMyelodysplastic SyndromesChina
-
National Heart, Lung, and Blood Institute (NHLBI)RecruitingChronic Lymphocytic LeukemiaUnited States
-
AbbVieCompletedCancer | Acute Myeloid Leukemia (AML)United States
-
M.D. Anderson Cancer CenterNational Cancer Institute (NCI)Active, not recruitingAcute Myeloid Leukemia | Acute Myeloid Leukemia Arising From Previous Myelodysplastic Syndrome | Chronic Myelomonocytic Leukemia | Myelodysplastic Syndrome | Recurrent Acute Myeloid Leukemia | Recurrent Chronic Myelomonocytic Leukemia | Refractory Acute Myeloid Leukemia | Refractory Chronic Myelomonocytic... and other conditionsUnited States
-
The Lymphoma Academic Research OrganisationInstitute of Cancer Research, United KingdomRecruitingMantle Cell LymphomaFrance, United Kingdom, Belgium
-
Montefiore Medical CenterM.D. Anderson Cancer Center; Flamingo Therapeutics NVRecruitingAcute Myeloid Leukemia | Myelodysplastic Syndromes | AML/MDSUnited States
-
Stichting Hemato-Oncologie voor Volwassenen NederlandNordic CLL Study GroupActive, not recruitingChronic Lymphocytic Leukemia in Relapse | Chronic Lymphocytic Leukemia in RemissionNetherlands, Belgium, Denmark, Finland, Norway, Sweden
-
French Innovative Leukemia OrganisationAbbVie; Janssen-Cilag Ltd.Active, not recruitingIntermediate Risk Chronic Lymphocytic Leukemia | Fit Patients | Risk-Adapted and MRD-Driven StrategyFrance
-
Institute of Hematology & Blood Diseases HospitalNot yet recruitingAcute Myeloid Leukemia
-
AstraZenecaTerminatedRelapsed or Refractory Acute Myeloid Leukemia (AML)United States
-
ImmunoGen, Inc.Jazz PharmaceuticalsActive, not recruitingAcute Myeloid LeukemiaUnited States, Germany, France, Spain, Italy, United Kingdom
-
Shanghai Jiao Tong University School of MedicineShanghai Clinical Research CenterRecruiting
-
Groupe Francophone des MyelodysplasiesBristol-Myers Squibb; AbbVieRecruitingUntreated Myelodysplastic SyndromeFrance